Cresco Labs (CRLBF) Share-based Compensation (2020 - 2026)
Cresco Labs' (CRLBF) quarterly Share-based Compensation came in at $5.3 million in Q1 2026, up 92.99% YoY from $2.7 million in Q1 2025, and up 169.33% on a QoQ basis from -$7.6 million in Q4 2025.
Cresco Labs (CRLBF) Share-based Compensation (2020 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Share-based Compensation data on file, last reported at $5.3 million in Q1 2026.
- Quarterly Share-based Compensation rose 92.99% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 80.05% YoY) and the FY2024 annual result came in at $14.2 million, down 13.4% from the prior year.
- Share-based Compensation grew to $5.3 million in Q1 2026, from -$7.6 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $7.5 million in Q1 2022 to a low of -$7.6 million in Q4 2025.
- A 5-year average of $3.5 million and a median of $3.5 million in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2025 — Share-based Compensation sank 304.59% — and 2026, when it soared 92.99%.
- Tracing CRLBF's Share-based Compensation over 5 years: stood at $5.3 million in 2022, then plunged by 42.76% to $3.0 million in 2023, then advanced by 22.8% to $3.7 million in 2024, then slumped by 304.59% to -$7.6 million in 2025, then surged by 169.33% to $5.3 million in 2026.
- The last three Share-based Compensation figures came in at $5.3 million (Q1 2026), -$7.6 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn | 3.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.26 Mn |
| Mar 31, 2026 | 5.26 Mn |
| Dec 31, 2025 | -7.58 Mn |
| Dec 31, 2025 | -7.58 Mn |
| Sep 30, 2025 | 2.31 Mn |
| Sep 30, 2025 | 2.31 Mn |
| Jun 30, 2025 | 2.55 Mn |
| Jun 30, 2025 | 2.55 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Mar 31, 2024 | 4.20 Mn |
| Mar 31, 2024 | 4.20 Mn |
| Dec 31, 2023 | 3.02 Mn |
| Dec 31, 2023 | 3.02 Mn |